Consumer devices to remain within Swedish pharma benefits scheme
This article was originally published in Clinica
Executive Summary
Consumer medical devices, such as stoma care products, will remain part of the Swedish pharmaceutical benefits scheme (LMF). According to an agreement between the government and the Swedish association of county councils (LF) earlier this month, the scheme will not to be altered in the near future, despite the appointment of a new health minister. Consumer devices will thus continue to be subsidised.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.